News

Small Changes Count in Type 2 Diabetes Patients

Publish date: October 6, 2011

 

FROM THE ANNUAL MEETING OF THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES

Dr. Heintjes reported having no conflicts of interest. Her employer, PHARMO, however, receives funding from numerous pharmaceutical companies, including Astra Zeneca, which sponsored the current study.

Pages

Recommended Reading

UN Adopts Noncommunicable Disease Declaration
MDedge Family Medicine
Fatty Liver Ups Risk of Cardiovascular Disease
MDedge Family Medicine
DPP-4 Inhibitors May Be Cardioprotective
MDedge Family Medicine
U.S. Diabetes-Free Life Expectancy on the Decline
MDedge Family Medicine
Intensive Glucose-Lowering Does Not Benefit Cognition
MDedge Family Medicine
Heart Failure Doubles 5-Year Fracture Risk
MDedge Family Medicine
Teriparatide Now Preferred Drug for Steroid-Induced Osteoporosis
MDedge Family Medicine
Rheumatologists 'Pretty Good' at Treating Steroid-Induced Osteoporosis
MDedge Family Medicine
Obesity May Explain Liver Cancer Hike Among Latinos
MDedge Family Medicine
Conventional LFTs Often Miss Liver Disease in Type 2 Diabetes
MDedge Family Medicine